Patterson Companies is a medical distribution business based in the US. Patterson Companies shares (PDCO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $20.06 – an increase of 2.5% over the previous week. Patterson Companies employs 7,600 staff and has a trailing 12-month revenue of around $6.5 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $20.06 |
|---|---|
| 52-week range | $19.45 - $31.26 |
| 50-day moving average | $21.07 |
| 200-day moving average | $24.46 |
| Wall St. target price | $26.30 |
| PE ratio | 11.0565 |
| Dividend yield | $1.04 (5.2%) |
| Earnings per share (TTM) | $1.77 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $20.41 from 2024-11-19
| 1 week (2024-11-14) | 4.29% |
|---|---|
| 1 month (2024-10-21) | -4.13% |
| 3 months (2024-08-21) | -17.77% |
| 6 months (2024-05-21) | -17.73% |
| 1 year (2023-11-21) | -36.77% |
|---|---|
| 2 years (2022-11-21) | -22.73% |
| 3 years (2021-11-19) | 29.6726 |
| 5 years (2019-11-21) | 30.29% |
Valuing Patterson Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Patterson Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Patterson Companies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, Patterson Companies shares trade at around 11x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Patterson Companies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0984. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Patterson Companies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Patterson Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $347.9 million.
The EBITDA is a measure of a Patterson Companies's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $6.5 billion |
|---|---|
| Operating margin TTM | 2.13% |
| Gross profit TTM | $1.4 billion |
| Return on assets TTM | 5.6% |
| Return on equity TTM | 16.28% |
| Profit margin | 2.58% |
| Book value | $10.80 |
| Market Capitalization | $1.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 48.37% of net profits
Recently Patterson Companies has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Patterson Companies shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Patterson Companies's case, that would currently equate to about $1.04 per share.
While Patterson Companies's payout ratio might seem fairly standard, it's worth remembering that Patterson Companies may be investing much of the rest of its net profits in future growth.
Patterson Companies's most recent dividend payout was on 31 October 2024. The latest dividend was paid out to all shareholders who bought their shares by 17 October 2024 (the "ex-dividend date").
Patterson Companies's shares were split on a 2:1 basis on 24 October 2004 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Patterson Companies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Patterson Companies shares which in turn could have impacted Patterson Companies's share price.
Over the last 12 months, Patterson Companies's shares have ranged in value from as little as $19.4475 up to $31.2589. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Patterson Companies's is 1.012. This would suggest that Patterson Companies's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; and practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, and patient engagement solutions, as well as clinical and patient education systems. This segment also provides a range of related services comprising software and design, maintenance and repair, and equipment financing services. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, and equipment, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.